Teragawa, Hiroki’s team published research in Internal medicine (Tokyo, Japan) in 2020-01-01 | CAS: 21829-25-4

Internal medicine (Tokyo, Japan) published new progress about coronary spasm; myocardial bridge; myocardial infarction with nonobstructive coronary arteries; vasospastic angina. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Product Details of C17H18N2O6.

Teragawa, Hiroki published the artcileThe Significance of Recognizing Myocardial Bridge in the Coronary Spasm Diagnosis in Myocardial Infarction with Nonobstructive Coronary Arteries., Product Details of C17H18N2O6, the main research area is coronary spasm; myocardial bridge; myocardial infarction with nonobstructive coronary arteries; vasospastic angina.

A 61-year-old man experienced chest oppression for 1 hour. He was positive for troponin T and underwent emergent coronary angiography (CAG), which did not reveal significant coronary stenosis. He was diagnosed with myocardial infarction with nonobstructive coronary arteries (MINOCA). We performed a spasm-provocation test, which revealed a focal spasm at the segment of the myocardial bridge. After receiving a calcium-channel blocker, he exhibited a good clinical course. Coronary spasm is considered an underlying cause of MINOCA; therefore, the presence of a myocardial bridge may help with the diagnosis.

Internal medicine (Tokyo, Japan) published new progress about coronary spasm; myocardial bridge; myocardial infarction with nonobstructive coronary arteries; vasospastic angina. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Product Details of C17H18N2O6.

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem